President-elect Donald Trump’s key appointments for roles in the Department of Justice, Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA) have sparked significant concern among cannabis advocates. Pam Bondi, Dave Weldon, and Dr. Marty Makary—Trump’s picks for Attorney General, CDC Director, and FDA Commissioner, respectively—have all expressed strong opposition to marijuana reform. Throw that in with Trump’s VP, JD Vance, saying that all marijuana is laced with Fentanyl now, and you get the point.
The Trump administration is preparing to move cannabis from Schedule I to Schedule III of…
Based on the ruling, products that are legal federally as well as at the state…
The drug’s history of healing and experimentation stretches from ancient China to American counterculture —…
The new partnership will spotlight the stories of people still behind bars for cannabis, support…
Colombia is moving forward with a controversial plan to euthanize dozens of invasive hippos descended…
Imported hashish sustained mountain economies for centuries—until modern legalization and market economics erased it almost…